Pharminent

FDA approves Lilly’s Jaypirca for first-line CLL and SLL

The FDA approved an expanded indication for Lilly’s Jaypirca as a first-line treatment for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma who do not have a 17p deletion.

FDA extends review of Novo’s haemophilia A drug denecimig

The FDA has extended its review of Novo’s experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.

AstraZeneca’s tozorakimab cuts COPD exacerbations in two phase 3 trials

AstraZeneca’s tozorakimab reduced moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in the replicate, double-blind, placebo-controlled phase 3 OBERON and TITANIA trials, cutting exacerbation rates by 29% and 34% among former smokers. The studies enrolled a total of 2,306 patients with symptomatic COPD and a history of at least two moderate exacerbations.

CSL licenses Alentis’ anti-claudin-1 antibody in $1.55B deal

CSL has licensed rights to a potentially first-in-class anti-claudin-1 antibody developed by Alentis in a deal that could be worth up to $1.55 billion.

Brenntag and dsm-firmenich expand GMP vitamin distribution partnership

Brenntag Pharma and dsm-firmenich entered a long-term global distribution partnership covering GMP-grade vitamins for biopharmaceutical manufacturing, giving Brenntag exclusive distribution rights in North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific for dsm-firmenich’s Biond portfolio of high-purity vitamins. The products will be marketed under the new BYPHAR brand.

Bayer plans $2.2B pharmaceutical manufacturing facility in Ohio

Bayer announced plans to invest $2.2 billion in a new pharmaceutical manufacturing facility in Ohio.

Ilant Health raises over $22M for obesity care model

Ilant Health, founded by Elina Onitskansky, has raised more than $22 million to pair weight loss drugs with dietitians, behavioral health and peer support.

Deisseroth, Hegemann and Nagel win 2026 Nobel Prize in Medicine

Karl Deisseroth, Peter Hegemann and Georg Nagel are the joint recipients of the 2026 Nobel Prize in Physiology or Medicine “for their discoveries concerning light-gated ion channels and optogenetics.”